CardioVascular BioTherapeutics, Inc.
CardioVascular BioTherapeutics, Inc.
1635 Village Center Circle, Suite 250
Las Vegas, NV 89134
1635 Village Center Circle, Suite 250
Las Vegas, NV 89134
Categories: Biotechnical Research, Commercial, Biotherapeutics, Drugs Acting On The Cardiovascular System, Except Diagnostic
CardioVascular BioTherapeutics, Inc. (OTC/BB: CVBT) is a biopharmaceutical company developing injectable and topical drug candidates formulated with its active pharmaceutical ingredient (API), Fibroblast Growth Factor-1 (FGF-1), which has multiple applications for the promotion of tissue regeneration. FGF-1 is a human protein manufactured using a proprietary technology that stimulates angiogenesis and tissue repair.
CVBT is continuing to advance its technical platform through clinical trials to specifically treat
impaired blood supply and damaged tissue associated with Severe Coronary Heart Disease (CHD), Dermal Ulcers, Peripheral Arterial Disease (PAD), Disc Ischemia, and bone repair.
Keywords: cardiovascular disease, heart disease, peripheral artery disease, PAD, wounds, wound healing, biotechnology, Nevada, Las Vegas, Summerlin, CHD, CAD, women's heart disease
CVBT is continuing to advance its technical platform through clinical trials to specifically treat
impaired blood supply and damaged tissue associated with Severe Coronary Heart Disease (CHD), Dermal Ulcers, Peripheral Arterial Disease (PAD), Disc Ischemia, and bone repair.
Keywords: cardiovascular disease, heart disease, peripheral artery disease, PAD, wounds, wound healing, biotechnology, Nevada, Las Vegas, Summerlin, CHD, CAD, women's heart disease
Customer Reviews for CardioVascular BioTherapeutics, Inc.
Be the first to review CardioVascular BioTherapeutics, Inc. - Use the thumbs to get started!
Click to Rate:
0 thumbs up, 0 thumbs down
0 thumbs up, 0 thumbs down
CardioVascular BioTherapeutics, Inc. has not yet completed their interview.
Contact CardioVascular BioTherapeutics, Inc.:
- ©2024 LasVegasNevadaBusinessList.com
- Privacy Policy
- FAQ
- Contact
This site has been visited 45,940 times